Furthermore, EZH2 overexpression also contributes to cancer development and progression via chromatin modifications, which occur as a result of the epigenetic activation of carcinogenic signalling cascades and the silencing of tumour suppressor genes; it has also played a role in cell proliferation, differentiation, invasion, and metastasis16. The gene discussed is EZH2; the disease is neoplasm.